Tuesday, December 05, 2006

Pfizer stops Canadian trials

This is the first article I've seen mentioning a Canadian connection to torcetrapib. It shouldn't be a surprise that trials were being done here. There are many studies going on that are North America wide and essentially disregard the border.

From the Globe and Mail:
Canadian patients who were trying Pfizer Inc.'s new cholesterol treatment, torcetrapib, are being asked to stop immediately, the drug maker's Canadian arm told the Globe and Mail Monday.

The news comes after Pfizer said Saturday it had halted development of its key new cholesterol treatment. An independent board monitoring a study for torcetrapib recommended that the work end because of an unexpected number of deaths. ...more

No comments: